×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Company: AD Neurovascular and Cerebral Vasculature Therapy Companies
company
1,200 words
KG: Ad
2026-03-28
kind:company
section:companies
topic:neurovascular
topic:cerebral-amyloid-angiopathy
topic:caa
topic:alzheimer-disease
topic:cerebral-blood-flow
topic:glymphatic
topic:pericytes
topic:therapeutics
Contents
AD Neurovascular and Cerebral Vasculature Therapy Companies
Knowledge Graph
Related Hypotheses (30)
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36
Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57
Purinergic Signaling Polarization Control
Score: 0.55
Circadian-Synchronized LRP1 Pathway Activation
Score: 0.53
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51
Mechanosensitive Ion Channel Reprogramming
Score: 0.51
Lipid Droplet Dynamics as Phenotype Switches
Score: 0.46
LRP1-Dependent Tau Uptake Disruption
Score: 0.44
Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.68
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65
CYP46A1 Overexpression Gene Therapy
Score: 0.63
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
SASP-Driven Aquaporin-4 Dysregulation
Score: 0.59
PARP1 Inhibition Therapy
Score: 0.58
Competitive APOE4 Domain Stabilization Peptides
Score: 0.56
Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.55
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54
Glymphatic System-Enhanced Antibody Clearance Reversal
Score: 0.54
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53
Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.51
Aquaporin-4 Polarization Rescue
Score: 0.51
Ganglioside Rebalancing Therapy
Score: 0.50
Lysosomal Calcium Channel Modulation Therapy
Score: 0.49
Orexin-Microglia Modulation Therapy
Score: 0.49
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.49
Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.48
Complement C1q Mimetic Decoy Therapy
Score: 0.48
APOE Isoform Expression Across Glial Subtypes
Score: 0.48
TET2-Mediated Demethylation Rejuvenation Therapy
Score: 0.47
Arginine Methylation Enhancement Therapy
Score: 0.46
Show 25 more
Related Analyses (18)
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Senescent cell clearance as neurodegeneration therapy
neurodegeneration · archived
GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
Show 13 more
Related Experiments (1)
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
See Also (15)
Senescent Cell Clearance in Neurodegeneration
mechanism · Pages share 8 hypotheses
RNA-Targeted Therapies in Neurodegeneration
mechanism · Pages share 8 hypotheses
PPAR Signaling Pathway in Neurodegeneration
mechanism · Pages share 8 hypotheses
Neurovascular Unit Dysfunction in Neurodegeneration
mechanism · Pages share 8 hypotheses
Endosomal Sorting Defects in Neurodegeneration
mechanism · Pages share 8 hypotheses
Endosomal-Lysosomal Pathway in Neurodegeneration
mechanism · Pages share 8 hypotheses
Cerebral Amyloid Angiopathy Pathway in Neurodegeneratio
mechanism · Pages share 8 hypotheses
Cerebral Amyloid Angiopathy in Neurodegeneration
mechanism · Pages share 8 hypotheses
Extracellular Vesicle and Tunneling Nanotube-Mediated S
mechanism · Pages share 8 hypotheses
Rotigotine and Rivastigmine Combination Therapy for Alz
clinical · Pages share 8 hypotheses
A Phase 3, Randomised, Double-blinded, Placebo-controll
clinical · Pages share 8 hypotheses
Wnt/β-Catenin Signaling Pathway in Neurodegeneration
mechanism · Pages share 7 hypotheses
WNK1-Bilirubin Signaling in Neuroinflammation and Neuro
mechanism · Pages share 7 hypotheses
vip-vasoactive-intestinal-peptide-signaling-neurodegene
mechanism · Pages share 7 hypotheses
VEGF Signaling and Cerebral Angiogenesis in Neurodegene
mechanism · Pages share 7 hypotheses
Show 10 more
Knowledge Graph (1 edges)
TDP-43
associated_with
Ad